Live feed
Filing
SC 13G/A
SC 13G/A0000935836-24-000723·Aligos Therapeutics, Inc.
Schedule 13G ownership disclosure
Aligos Therapeutics Inc
Security class unavailable · CUSIP: 01626L204
Event date: 2024-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 356,117
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-24-000723
- Form type
- SC 13G/A
- Filer
- Aligos Therapeutics, Inc.
- CIK
- CIK 1799448
- Filed
- Nov 14, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership